News Search Results
Feb 24, 2026, 07:00 ET ERS Genomics launches new Early Access Express License
cell lines and animal models for drug screening, bioproduction of antibodies and therapeutic proteins, animal and agricultural biotechnology, synthetic biology, including production of enzymes, food ingredients, and bio-based chemicals.Current ERS licensees include GSK, Merck, Bayer, Thermo Fisher
More news about: ERS Genomics
Feb 20, 2026, 09:15 ET AI Takes Flight: Five Companies Advancing Defense and Aerospace Intelligence
environmental evaluation, with applications spanning cognitive and physiological monitoring, flexible electronics, additive smart materials, and synthetic biology. AeroVironment continues to expand its defense technology portfolio beyond its established Switchblade loitering munition and Puma unmanned
More news about: USA News Group
Feb 18, 2026, 08:23 ET BiomEdit Initiates Final Field Safety Trial for Non-Antibiotic Poultry Biologic, Advancing Toward USDA Conditional Licensure
performance."About BiomEditBiomEdit is an animal health biotechnology company leveraging the power of the microbiome and synthetic biology to develop next-generation solutions for livestock and pet health. Founded in 2022, BiomEdit is backed by leading investors including Anterra
More news about: BiomEdit
Feb 18, 2026, 08:00 ET Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Feb 12, 2026, 17:52 ET UTulsa's Hurricane Ventures announces investment in BioReact
shorten development cycles. The platform requires no coding expertise and has applications across industries like biopharma, industrial biotech and synthetic biology."The support from The University of Tulsa and Hurricane Ventures allows us to accelerate development of software that genuinely serves
More news about: The University of Tulsa
Feb 10, 2026, 09:04 ET Simplicis Named Launch Partner For The Beckman Coulter Life Sciences Echo Ready Digital Solutions Program
contactless liquid dispensing and supports key workflows in early drug discovery as well as emerging applications in biotherapeutics engineering, synthetic biology, and nanotechnology. The technology supports highly combinatorial workflows, miniaturization, and enables the production of high-quality assay-ready
More news about: Simplicis
Feb 05, 2026, 14:00 ET Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Feb 03, 2026, 00:00 ET UAE Partners with Colossal Biosciences to Protect Biodiversity and Champion the Future of Life on Earth
our greatest challenges," said Museum of the Future, Executive Director, Majed Al Mansoori "By working with Colossal Biosciences, leaders in synthetic biology and conservation, we are taking a bold step to advance science that safeguards our planet, restores ecosystems, and builds a sustainable legacy
More news about: Colossal Biosciences
Jan 29, 2026, 12:52 ET IEEE Reveals 2026 Predictions for Top Technology Trends
significant potential to disrupt the status quo. These "ones to watch" include Electric Vertical Take-Off and Landing (eVTOL) vehicles, fusion energy, synthetic biology, and the tighter convergence of quantum-High Performance Computing-AI.Recommended actionsIn addition to outlining the trends
More news about: IEEE Computer Society
Jan 28, 2026, 15:51 ET Voyager Closes $275M Fund II to Invest in the Foundational Industries of the Future
experience building and operating companies and creating policy across energy, advanced materials, and mobility. Sarah conducted research in synthetic biology at MIT and helped build Modern Meadow, the world's first company making bio-fabricated leather, as part of its founding team, and co-founded sustainable
More news about: Voyager Ventures
Jan 28, 2026, 15:33 ET Voyager Closes $275M Fund II to Invest in the Foundational Industries of the Future
experience building and operating companies and creating policy across energy, advanced materials, and mobility. Sarah conducted research in synthetic biology at MIT and helped build Modern Meadow, the world's first company making bio-fabricated leather, as part of its founding team, and co-founded sustainable
More news about: Voyager Ventures
Jan 26, 2026, 10:49 ET 2026 Edition Of The Stanford Emerging Technology Review Offers Policymakers And Business Leaders New Insights Into The Implications Of Frontier Technologies
motivation behind the Stanford Emerging Technology Review."The 2026 SETR surveys ten frontier technologies: AI, biotechnology and synthetic biology, cryptography and computer security, energy, materials science, neuroscience, quantum technologies, robotics, semiconductors, materials science,
More news about: Hoover Institution at Stanford University
Jan 20, 2026, 10:00 ET Think Bioscience Raises $55M in Oversubscribed Series A
Think Bioscience develops small molecule drugs for historically challenging drug targets by using synthetic biology to uncover novel footholds for medicinal chemistry (e.g., protein pockets). Their lead program targets mutants that cause Noonan syndrome, a genetic
More news about: Think Bioscience
Jan 20, 2026, 09:00 ET K18 Taps GlamBOT Director Cole Walliser for Global Hair Flip Challenge and Guinness World Record™ Attempt for a Cause
salon-exclusive damage repair service that protects, strengthens, and preserves hair health through even extreme salon services. As the leader in synthetic biology for beauty, K18 sets itself apart by addressing hair health from the inside out, rather than relying on surface-level solutions. With over 20
More news about: K18 Biomimetic Hairscience
Jan 20, 2026, 05:09 ET GENEIII Sets the Global Benchmark for Ergothioneine with Pharmaceutical-Grade Purity and Human Clinical Validation
dual track of "Global Layout of Frontier Research" and "Official National Certification for a Leading Brand," demonstrating the new heights in synthetic biology to the global market.
More news about: GENEIII
Jan 15, 2026, 23:23 ET The AKG and Ca-AKG of Xin Tianhe have passed the US Self-GRAS certification
manufacturing as its core competitiveness. Relying on the R&D technical strength of its parent company, it has built an internationally advanced synthetic biology technology platform, and has successively obtained KOSHER, FSSC 22000, HALAL, etc., and its technology and quality
More news about: XinTianhe Biotechnology
Jan 15, 2026, 11:45 ET Transition Metal Solutions Closes Oversubscribed $6M Seed to Reinvent Bio-Based Copper Recovery
communities from doing what they naturally evolved to do," said Milshteyn, who has more than 20 years of experience in biophysics, metagenomics, and synthetic biology.When tested on a low-grade primary sulfide ore, lab results showed an increase in copper recovery from 60 to 90 percent. Experiments on
More news about: Transition Metal Solutions
Jan 13, 2026, 10:01 ET Algae-Based Biofuel Market to Reach USD 19.16 Billion by 2032 as Sustainable Aviation Fuel and Energy Security Redefine the Global Fuel Mix
primarily serves pilot and demonstration-scale projects, with activity concentrated in North America.ViridosViridos applies synthetic biology and metabolic engineering to enhance algae productivity for low-carbon fuels and chemicals. The company's innovation centers on strain optimization
More news about: DataM Intelligence 4 Market Research LLP
Jan 13, 2026, 07:00 ET Synthego Announces Entry into Molecular Biology and Clinical Diagnostic Reagents Market
PortfolioThe decision to enter the molecular and clinical diagnostics space is a strategic one for Synthego, leveraging its world-class expertise in synthetic biology and CRISPR-based technologies. By providing novel, engineered enzyme solutions designed for more robust and rapid molecular assays with reagents
More news about: Synthego
Jan 08, 2026, 11:39 ET Bionova Scientific and Syenex Forge Strategic Alliance to Expand Access to High-Quality Plasmid DNA for Advanced Therapies
SyenexSyenex is an open-science genetic medicines platform company that enables developers to program cells with precision and scale. Leveraging synthetic biology and a global network of contract development and manufacturing organizations (CDMOs), Syenex provides plug-and-play delivery platforms, spanning
More news about: Bionova Scientific
Jan 08, 2026, 03:30 ET Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO to advance Nanosyringe-enabled intracellular medicines
trials COVENTRY, England, Jan. 8, 2026 /PRNewswire/ -- NanoSyrinx, a synthetic biology company developing Nanosyringes™ as a novel platform for targeted intracellular delivery of biologic therapeutics, today announced the appointment
More news about: NanoSyrinx
Dec 22, 2025, 13:21 ET Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach
Combining recent advancements in synthetic biology with cutting-edge detection technology, the team expects to develop both a highly innovative orally administered pill containing specially engineered,
More news about: Ginkgo Bioworks
Dec 18, 2025, 09:00 ET Freda Key C Presents Advanced Recombinant Collagen Delivery Technology at SCC79
to account for 44.9% of the total collagen market.Freda's presentation builds on years of research into recombinant collagen. Using its synthetic biology platform, the company has developed highly active, high-purity recombinant humanized Type III collagen and studied its performance in ex vivo
More news about: Shandong Freda Biotech Co., Ltd.
Dec 17, 2025, 08:00 ET Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Dec 15, 2025, 23:55 ET Breaking the "Untreatable": Biostar Pharma's UTD1 Achieves First Patient Dosing in U.S. for Pivotal Clinical Trial for Breast Cancer Brain Metastases
patients.About BiostarBiostar is an integrated biopharma company focusing on the development of innovative anti-cancer drugs utilizing its synthetic biology R&D platform. The company is listed on the Hong Kong Stock Exchange (HK 2563) in 2024. We are actively selecting reliable global partners
More news about: Biostar Pharma, Inc.